Summary
PHMBIO+ is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €20,460 and a net result of €59,137. Equity is growing by about 7.4% per year across the filed financial years. Its solvency ranks better than 9% of 604 sector peers (NACE 66, financial year 2025). The company has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
16-02
Gazette deed
Appointment: Philippe Monteyne (statutory director)Reserve release · Amendment of the articles5 facts ▸
- General meeting, 06-12-2023
- Other provision, “constatation conversions de plein droit depuis deuxième phase CSA, compte de capitaux propres statutairement indisponibles” (deed in French)
- Reserve release, “suppression, rendre disponibles ces moyens pour distribution” (deed in French)
- Amendment of the articles
- Director appointment, Philippe Monteyne (statutory director)
Show earlier events
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.